Development of nephrotic syndrome after administration of sorafenib in a case of metastatic renal cell carcinoma

Case Reports in Medicine

Volumn 2011, Issue , 2011, Pages

  Okuno, Yumiko ^a   Kume, Haruki ^a   Hosoda, Chihiro ^a   Homma, Yukio ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; DIURETIC AGENT; SORAFENIB;

ADULT; ALBUMIN BLOOD LEVEL; ASCITES; CASE REPORT; CREATININE BLOOD LEVEL; DIURETIC THERAPY; DRUG FEVER; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EDEMA; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MALE; MEDICAL HISTORY; NEPHROTIC SYNDROME; PARTIAL NEPHRECTOMY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SODIUM RESTRICTION; SUPPLEMENTATION; WEIGHT GAIN;

EID: 84860243041     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2011/710216     Document Type: Review

References (10)

1. Huang W. C., Levey A. S., Serio A. M., Snyder M., Vickers A. J., Raj G. V., Scardino P. T., Russo P., Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study The Lancet Oncology 2006 7 9 735 740 (Pubitemid 44283660)
2. McKiernan J., Simmons R., Katz J., Russo P., Natural history of chronic renal insufficiency after partial and radical nephrectomy Urology 2002 59 6 816 820 (Pubitemid 34522166)
3. Rolleman E. J., Weening J., Betjes M. G. H., Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma Nephrology Dialysis Transplantation 2009 24 6 2002 2003
4. Overkleeft E. N., Goldschmeding R., van Reekum F., Voest E. E., Verheul H. M., Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib Annals of Oncology 2010 21 1 184 185
5. Winn S. K., Ellis S., Savage P., Sampson S., Marsh J. E., Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect? Nephrology Dialysis Transplantation 2009 24 2 673 675
6. Patel T. V., Morgan J. A., Demetri G. D., George S., Maki R. G., Quigley M., Humphreys B. D., A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib Journal of the National Cancer Institute 2008 100 4 282 284 (Pubitemid 351480534)
7. Chen Y. S., Chen C. L., Wang J. S., Nephrotic syndrome and acute renal failure apparently induced by sunitinib Case Reports in Oncology 2009 2 172 176
8. Jonkers I. J., van Buren M., Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma Clinical and Experimental Nephrology 2009 13 4 397 401
9. Costero O., Picazo M. L., Zamora P., Romero S., Martinez-Ara J., Selgas R., Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy Nephrology Dialysis Transplantation 2010 25 3 1001 1003
10. Wu S., Kim C., Baer L., Zhu X., Bevacizumab increases risk for severe proteinuria in cancer patients Journal of the American Society of Nephrology 2010 21 8 1381 1389